All articles are linked to PubMed where available.
If you are interested in re-prints of any articles, please contact pr@austrianova.com with the details.
2000 – 2004
1998 – 1999
2012 |
| Brandtner, E.M., Muendlein, A., Salmons, B. and H. Drexel. (2012) Inselzellen vor dem Immunangriff schuetzen. 40. Jahrestagung der Oesterreichischen Diabetes Gesellschaft, November 2012, pages 6-7. [view article: in German] |
| Salmons, B. and Gunzburg, W.H. (2012) Suicide gene for cancer therapy. BioSpectrum Asia Ed., Vol. 7, Issue 15, August 15, pages 15-19. [view article] |
| Hlavaty J., Petznek H., Holzmueller H., Url A., Jandl G., Berger, A., Salmons, B., Gunzburg, W.H., and M., Renner (2012) Evaluation of a Gene-Directed Enzyme-Product Therapy (GDEPT) in Human Pancreatic Tumor Cells and Their Use as In Vivo Models for Pancreatic Cancer. PLoS One, July 16;7(7):1-9.e40611. doi:10.1371/journal.pone.0040611 |
| Ortner, V., Kaspar, C., Halter, C. Toellner, L., Mykhaylyk, O., Walzer, J., Gunzburg, W.H., Dangerfield, J.A., Hohenadl, C. T. Czerny, (2010) Magnetic field-controlled gene expression in encapsulated cells. Journal of Controlled Release, Mar 28;158(3):424-32. |
2010 |
| Chua, A.J.S., Brandtner, E.M., Dangerfield, J.A., Salmons, B., Gunzburg, W.H. and Ng, M.L. (2010) A novel cell encapsulation mode for delivery of therapeutic antibodies against West Nile Virus infections that maintains steady plasma antibody levels throughout therapy. International Congress on Infectious Diseases (ICID): Abstract 24.010. doi:10.1016/jijid.2010.02 |
| Salmons, B., Dangerfield, J.A., Brandtner, E.M., Toa, P., Tan, W Jin and Gunzburg, W.H. (2010) A method for protecting therapeutic cells and microenvironment containment in patients for gene and cell therapies: a clinically proven enabling cell encapsulation technology. Human Gene Therapy 21 1476-1477 |
| Salmons, B., Brandtner, E.M., Hettrich, K. Wagenknecht, W., Volkert, B., Fischer, S., Dangerfield, J.A. and Gunzburg, W.H. (2010) Encapsulated cells to focus the metabolic activation of anti-cancer drugs. Current Opinion in Molecular Therapeutics 12(4):450-60 |
| Salmons, B. and Gunzburg, W.H. (2010) Therapeutic application of cell microencapsulation in cancer. Advances in Experimental Medicine and biology 670, 92-103. |
2009 |
| Lear, M.J., Salmons, B., Gunzburg, W.H., and Dangerfield, J. (2009) Singapore R&D and globetrotting. Biotechnology Journal 4, 179-85 |
| Gunzburg, W.H. and Salmons, B. (2009) Stem cell therapies: on track but suffer setback. Current Opinion in Molecular Therapeutics 11, 360-363 |
| Salmons, B. and Gunzburg, W.H. (2009) Therapeutic application of cell microencapsulation in cancer. In: Therapeutic Applications of Cell Microencapsulation. Eds: J.L. Pedraz and G. Orive. Landes Bioscience publishing. in press |
| Salmons, B., Hauser, O., Gunzburg W.H. and Tabotta W. (2009) Cell microencapsulation in cancer therapy. In: The bioartificial pancreas and other biohybrid therapies. Eds: Pierre Hallé, Paul de Vos and Lawrence Rosenberg. Research Signpost publishing. pp595-606 |
| Stiegler, P., Stadlbauer, V., Hackl, F., Iberer F., Lackner, C., Hauser, O., Schaffellner, S., Strunk, D., Tscheliessnigg, K.H. (2009) Xenotransplantation of NaCS microencapsulated porcine islet cells in diabetic rats. Organ Biology, 16(1) : 104 |
2007 |
| Salmons, B., Hauser, O., Gunzburg, W.H. and Tabotta, W. (2007) GMP production of an encapsulated cell therapy product: issues and considerations. BioProcessing Journal 4, 36-43 |
| Samel, S. and Löhr, M. (2007) Targeted intra-abdominal chemotherapy for peritoneal carcinomatosis. Cancer Treatment and Research 134, 469-82 |
2006 |
| Sahel, S., Keese, M., Lux, A., Jesnowski, R., Prosst, R., Saller, R., Hafner, M., Sturm, J., Post, S. and Löhr, M. (2006) Peritoneal cancer treatment with CYP2B1 transfected, microencapsulated cells and ifosfamide. Cancer Gene Therapy. 13, 65-73 |
| Stadlbauer, V., Stiegler, P.B., Schaffellner, S., Hauser, O., Halwachs, G., Iberer, F., Tscheliessnigg, K.H. and Lackner, C. (2006) Morphological and functional characterization of a pancreatic beta-cell line microencapsulated in sodium cellulose sulfate/poly(diallyldimethylammonium chloride). Xenotransplantation 13, 337-344 |
| Stiegler, P.B., Stadlbauer, V., Schaffellner, S., Halwachs, G., Lackner, C., Hauser, O., Iberer, F. and Tscheliessnigg, K. (2006) Cryopreservation of insulin-producing cells microencapsulated in sodium cellulose sulfate. Transplantation Procedures 38, 3026-30 |
2005 |
| Schaffellner, S., Stadlbauer, V., Stiegler, P., Hauser, O., Halwachs, G., Lackner, C., Iberer, F. and Tscheliessnigg, K.H. (2005) Porcine islet cells microencapsulated in sodium cellulose sulfate. Transplantation Procedures 37, 248-452 |
| Ryschich, E., Jesnowski, R., Ringel, J., Harms, W., Fabian, O.V., Saller, R., Schrewe, M., Engel, A., Schmidt, J. and Löhr, M. (2005) Combined therapy of experimental pancreatic cancer with CYP2B1 producing cells: low-dose ifosfamide and local tumor irradiation. International Journal of Cancer 113, 649-53 |
| Günzburg, W.H. and Salmons, B. (2005) Cell and gene therapy to improve cancer treatment. Acta Biochimica Polonica 52, 601-607 |
